FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Holger Palmedo

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Physiology

Glomerular Filtration Rate

Co-author Network

Publications

TOP 3
Hans-Jürgen Biersack; Jan Bucerius; Samer Ezziddin; Stefan Guhlke; Furn F Knapp; Holger Palmedo; Stefan Rogenhofer; Andrej Andris; Dirk von Mallek
Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis.
Thomas Gerhardt; Holger Palmedo; Uwe Pöge; Tilman Sauerbruch; Birgit Stoffel-Wagner; Rainer P Woitas
Creatinine-based glomerular filtration rate estimation in patients with liver disease: the new Chronic Kidney Disease Epidemiology Collaboration equation is not better.
Thomas Gerhardt; Holger Palmedo; Uwe Pöge; Tilman Sauerbruch; Birgit Stoffel-Wagner; Rainer P Woitas
Is beta-trace protein an alternative marker of glomerular filtration rate in liver transplant recipients?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Holger Palmedo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Hans-Jürgen Biersack; Jan Bucerius; Samer Ezziddin; Stefan Guhlke; Furn F Knapp; Holger Palmedo; Stefan Rogenhofer; Andrej Andris; Dirk von Mallek
Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1721-6.
2011: Thomas Gerhardt; Holger Palmedo; Uwe Pöge; Tilman Sauerbruch; Birgit Stoffel-Wagner; Rainer P Woitas
Creatinine-based glomerular filtration rate estimation in patients with liver disease: the new Chronic Kidney Disease Epidemiology Collaboration equation is not better.
European journal of gastroenterology & hepatology 2011;23(11):969-73.
2011: Thomas Gerhardt; Holger Palmedo; Uwe Pöge; Tilman Sauerbruch; Birgit Stoffel-Wagner; Rainer P Woitas
Is beta-trace protein an alternative marker of glomerular filtration rate in liver transplant recipients?
Liver international : official journal of the International Association for the Study of the Liver 2011;31(9):1345-51.
2011: Jan Bucerius; Alexius Y Joe; Ellen Herder; Holger Brockmann; Kim Biermann; Holger Palmedo; Klaus Tiemann; Hans-Jürgen Biersack
Pathological 99mTc-sestamibi myocardial perfusion scintigraphy is independently associated with emerging cardiac events in elderly patients with known or suspected coronary artery disease.
Acta radiologica (Stockholm, Sweden : 1987) 2011;52(1):52-8.
2010: Jan Bucerius; Alexius Y Joe; Ellen Herder; Holger Brockmann; Michael Reinhardt; Holger Palmedo; Klaus Tiemann; Hans-Jürgen Biersack
Significant association of female gender with lower degree of pathological 99mTc-sestamibi scintigraphy results as well as higher cardiac-related deaths free survival in elderly patients.
Medizinische Klinik (Munich, Germany : 1983) 2010;105(12):901-9.
2009: Jan Bucerius; Bettina Buchholz; Holger Strunk; Holger Palmedo; Hans-Jürgen Biersack
Avoidance of invasive diagnostic and harmful therapeutic measures in a patient with malignant fibrous histiocytoma and extensive clinically occult metastases.
Journal of the National Medical Association 2009;101(9):953-5.
2009: Jan Bucerius; Alexius Y Joe; Ellen Herder; Holger Brockmann; Kim Biermann; Holger Palmedo; Klaus Tiemann; Hans-Jürgen Biersack
Hemodynamic variables during stress testing can predict referral to early catheterization but failed to show a prognostic impact on emerging cardiac events in patients aged 70 years and older undergoing exercise (99m)Tc-sestamibi myocardial perfusion scintigraphy.
The international journal of cardiovascular imaging 2009;25(6):569-79.
2009: Thomas Gerhardt; Birgit Terjung; P Knipper; Holger Palmedo; Rainer P Woitas; J Kalff; Tilman Sauerbruch; Ulrich Spengler
Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation.
European journal of medical research 2009;14(5):210-5.
2008: Jan Bucerius; Anna Naubereit; Alexius Y Joe; Samer Ezziddin; Katharina Biermann; Jörn Risse; Holger Palmedo; Johannes Oldenburg; Hans-Jürgen Biersack
Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy.
Thrombosis and haemostasis 2008;100(5):803-9.
2008: Baljinder Singh; Samer Ezziddin; Holger Palmedo; Michael Reinhardt; Holger Strunk; Thomas Tüting; Hans-Jürgen Biersack; Hojjat Ahmadzadehfar
Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Melanoma research 2008;18(5):346-52.
2008: Andrew S Kennedy; William A Dezarn; Patrick McNeillie; Doug Coldwell; Charles Nutting; Dennis Carter; Ravi Murthy; Steven Rose; Richard R P Warner; David Liu; Holger Palmedo; Carroll Overton; Bonita Jones; Riad Salem
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
American journal of clinical oncology 2008;31(3):271-9.
2008: Jan Bucerius; Jörn Schmaljohann; Ingrid Böhm; Holger Palmedo; Stefan Guhlke; Klaus Tiemann; Hans Heinz Schild; Hans-Jürgen Biersack; Christoph Manka
Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results.
European journal of nuclear medicine and molecular imaging 2008;35(4):815-20.
2008: Uwe Pöge; Thomas Gerhardt; Birgit Stoffel-Wagner; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
Beta-trace protein-based equations for calculation of GFR in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(3):608-15.
2008: Holger Palmedo; C Grohé; Y Ko; Selçuk Tasci
PET and PET/CT with F-18 fluoride in bone metastases.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2008;170():213-24.
2008: Holger Palmedo; M Wolff
PET and PET/CT in thyroid cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2008;170():59-70.
2007: John R Buscombe; Giovanni Paganelli; Zeynep E Burak; Wendy Waddington; Jean Maublant; Enrique Prats; Holger Palmedo; Orazio Schillaci; Lorenzo Maffioli; Michael Lassmann; Carlo Chiesa; Emilio Bombardieri; Arturo Chiti
Sentinel node in breast cancer procedural guidelines.
European journal of nuclear medicine and molecular imaging 2007;34(12):2154-9.
2007: Uwe Pöge; Thomas Gerhardt; Birgit Stoffel-Wagner; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
Can modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(12):3610-5.
2007: Hojjat Ahmadzadehfar; Holger Palmedo; Holger Strunk; Hans-Jürgen Biersack; Elham Habibi; Samer Ezziddin
False positive 18F-FDG-PET/CT in a patient after talc pleurodesis.
Lung cancer (Amsterdam, Netherlands) 2007;58(3):418-21.
2007: Jan Bucerius; Samer Ezziddin; Holger Brockmann; Holger Palmedo; Hans-Jürgen Biersack
Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(9):606-9.
2007: Jan Bucerius; Thomas Wallny; Hans H Brackmann; Alexius Y Joe; Roland Roedel; Hans-Jürgen Biersack; Holger Palmedo
Rhenium-186 hydroxyethylidenediphosphonate (186Re HEDP) for the treatment of hemophilic arthropathy: first results.
The Clinical journal of pain 2007;23(7):612-8.
2007: Jan Bucerius; Alexius Y Joe; Ina Lindstaedt; Agnieszka Manka-Waluch; Karl Reichmann; Samer Ezziddin; Holger Palmedo; Hans-Jürgen Biersack
Single- vs. dual-head SPECT for detection of myocardial ischemia and viability in a large study population.
Clinical imaging 2007;31(4):228-33.
2007: Jörn H Risse; D Pauleit; Holger Palmedo; Hans Bender; Jan Bucerius; Samer Ezziddin; V Klein; Frank Grünwald; Hans-Jürgen Biersack; Karl Reichmann
Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry.
Nuklearmedizin. Nuclear medicine 2007;46(5):192-7.
2007: Jan Bucerius; Hojjat Ahmadzadehfar; Niclas Hortling; Alexius Y Joe; Holger Palmedo; Hans-Jürgen Biersack
Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.
Prostate cancer and prostatic diseases 2007;10(3):307-10.
2006: Agnieszka Manka-Waluch; Holger Palmedo; Michael Reinhardt; Alexius Y Joe; Christoph Manka; Stefan Guhlke; Hans-Jürgen Biersack; Jan Bucerius
Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
Annals of nuclear medicine 2006;20(10):663-70.
2006: Thomas Gerhardt; Uwe Pöge; Birgit Stoffel-Wagner; Manuela Ahrendt; Martin Wolff; Ulrich Spengler; Holger Palmedo; Tilman Sauerbruch; Rainer P Woitas
Estimation of glomerular filtration rates after orthotopic liver transplantation: Evaluation of cystatin C-based equations.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(11):1667-72.
2006: Alexius Y Joe; Thomas Tielmann; Jan Bucerius; Michael Reinhardt; Holger Palmedo; Wolfgang Maier; Hans-Jürgen Biersack; Astrid Zobel
Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(8):1319-25.
2006: Uwe Pöge; Thomas Gerhardt; Birgit Stoffel-Wagner; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients.
Kidney international 2006;70(1):204-10.
2006: Dirk von Mallek; Bjorn O Backhaus; Stefan C Müller; Alexander Matthies; Holger Palmedo; Ursula Jaeger; Hans-Jürgen Biersack; Michael Reinhardt
[Technical limits of PET/CT with 18FDG in prostate cancer].
Aktuelle Urologie 2006;37(3):218-21.
2006: Jan Bucerius; Alexius Y Joe; Holger Palmedo; Michael Reinhardt; Hans-Jürgen Biersack
Impact of short-term hypothyroidism on systemic anticoagulation in patients with thyroid cancer and coumarin therapy.
Thyroid : official journal of the American Thyroid Association 2006;16(4):369-74.
2006: Holger Palmedo; Jan Bucerius; Alexius Y Joe; Holger Strunk; Niclas Hortling; Susanne Meyka; Roland Roedel; Martin Wolff; Eva Wardelmann; Hans-Jürgen Biersack; Ursula Jaeger
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(4):616-24.
2006: Uwe Pöge; Thomas Gerhardt; Birgit Stoffel-Wagner; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
Prediction of glomerular filtration rate in renal transplant recipients: cystatin C or modification of diet in renal disease equation?
Clinical transplantation 2006;20(2):200-5.
2006: Agnieszka Manka-Waluch; Holger Palmedo; Selçuk Tasci; Hans-Jürgen Biersack; Jan Bucerius
False-positive 131I whole-body scan and shrinkage of a pulmonary aspergilloma under 131I therapy in a patient with thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2006;16(2):197-8.
2006: Samer Ezziddin; Timur Logvinski; Charlotte Yong-Hing; Hojjat Ahmadzadehfar; Hans-Peter Fischer; Holger Palmedo; Jan Bucerius; Michael Reinhardt; Hans-Jürgen Biersack
Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):223-33.
2006: Holger Palmedo; Horst Urbach; Hans Bender; Uwe Schlegel; Ingo G H Schmidt-Wolf; Alexander Matthies; Michael Linnebank; Alexius Y Joe; Jan Bucerius; Hans-Jürgen Biersack; Hendrik Pels
FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.
European journal of nuclear medicine and molecular imaging 2006;33(2):164-8.
2006: Jörn H Risse; C Rabe; D Pauleit; Karl Reichmann; C Menzel; Frank Grünwald; Holger Strunk; Hans-Jürgen Biersack; Holger Palmedo
Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort.
Nuklearmedizin. Nuclear medicine 2006;45(4):185-92.
2005: Holger Brockmann; Alexius Y Joe; Holger Palmedo; Hans-Jürgen Biersack
A patient with acromegaly presenting with polyostotic fibrous dysplasia on bone scan: McCune-Albright syndrome.
Clinical nuclear medicine 2005;30(12):813-5.
2005: Thomas Heinicke; Eva Wardelmann; Tilman Sauerbruch; Henriette J Tschampa; Axel Glasmacher; Holger Palmedo
Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Anticancer research 2005;25(6C):4591-4.
2005: Holger Strunk; Jan Bucerius; Ursula Jaeger; Alexius Y Joe; Sebastian Flacke; Michael Reinhardt; Niclas Hortling; Holger Palmedo
[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2005;177(9):1235-41.
2005: Holger Brockmann; Kai Wilhelm; Alexius Y Joe; Holger Palmedo; Hans-Jürgen Biersack
Nasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature.
Clinical nuclear medicine 2005;30(8):543-5.
2005: Uwe Pöge; Thomas Gerhardt; Birgit Stoffel-Wagner; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
beta-Trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients.
Clinical chemistry 2005;51(8):1531-3.
2005: Uwe Pöge; Thomas Gerhardt; Holger Palmedo; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P Woitas
MDRD equations for estimation of GFR in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1306-11.
2005: B Kinkel; Holger Palmedo; Alexius Y Joe; G Albert; Hans-Jürgen Biersack
[Unspecific abdominal complaints: diagnosis with szintigraphy].
Der Internist 2005;46(3):329-33.
2005: Hans-Jürgen Biersack; Samer Ezziddin; Jörn H Risse; Hans Bender; Holger Palmedo
[Therapy with radioisotopes in oncology. Palliative and curative approaches].
Schmerz (Berlin, Germany) 2005;19(1):9-17.
2005: Alexander Matthies; Michael Reinhardt; Holger Palmedo; Samer Ezziddin; B Abramowski; W Kuhn; Hans-Jürgen Biersack; Dirk von Mallek
Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
Cancer investigation 2005;23(2):119-22.
2004: R Rödel; H J Straehler-Pohl; Holger Palmedo; Karl Reichmann; Ursula Jaeger; Michael Reinhardt; Hans-Jürgen Biersack
[PET/CT imaging in head and neck tumors].
Der Radiologe 2004;44(11):1055-9.
2004: Holger Palmedo; Jan Bucerius
Radionuclide therapy in oncology: repeated administrations of high dose rate radiopharmaceuticals.
European journal of nuclear medicine and molecular imaging 2004;31(11):1556.
2004: Jörn H Risse; Christian Menzel; Frank Grünwald; Holger Strunk; Hans-Jürgen Biersack; Holger Palmedo
Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Romanian journal of gastroenterology 2004;13(2):119-24.
2004: Hans-Jürgen Biersack; Hans Bender; Holger Palmedo
FDG-PET in monitoring therapy of breast cancer.
European journal of nuclear medicine and molecular imaging 2004;31 Suppl 1():S112-7.
2004: Alexander Matthies; Samer Ezziddin; Eva-Maria Ulrich; Holger Palmedo; Hans-Jürgen Biersack; Hans Bender; Stefan Guhlke
Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT.
European journal of nuclear medicine and molecular imaging 2004;31(5):797.
2003: Hans-Jürgen Biersack; Holger Palmedo
Locally advanced breast cancer: is PET useful for monitoring primary chemotherapy?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(11):1815-7.
2003: Holger Palmedo; Agnieszka Manka-Waluch; Peter Albers; Ingo G H Schmidt-Wolf; Michael Reinhardt; Samer Ezziddin; Alexius Y Joe; Roland Roedel; Rolf Fimmers; Furn F Knapp; Stefan Guhlke; Hans-Jürgen Biersack
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2869-75.
2003: R Rödel; A Ebert; Karl Reichmann; Michael Reinhardt; Holger Palmedo; Hans-Jürgen Biersack; Dirk von Mallek
[Effectiveness of syringe shieldings using radionuclides in radiation synovectomy].
Nuklearmedizin. Nuclear medicine 2003;42(1):50-3.
2002: Holger Palmedo; Jenne Hensel; Michael Reinhardt; Dirk von Mallek; Alexander Matthies; Hans-Jürgen Biersack
Breast cancer imaging with PET and SPECT agents: an in vivo comparison.
Nuclear medicine and biology 2002;29(8):809-15.
2002: Dirk von Mallek; Alexius Y Joe; Holger Palmedo; Alexander Matthies; Hans-Jürgen Biersack; Michael Reinhardt
Improved diagnosis of advanced bone marrow metastases by means of radiolabeled antigranulocyte antibodies.
Journal of experimental & clinical cancer research : CR 2002;21(3):421-4.
2002: Alfred Schmitz; Jörn H Risse; J Textor; D Zander; H-J Biersack; Ottmar Schmitt; Holger Palmedo
FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2002;13(9):755-61.
2002: Michael Reinhardt; Ingo Brink; Alexius Y Joe; Dirk von Mallek; Samer Ezziddin; Holger Palmedo; Thomas M Krause
Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
European journal of nuclear medicine and molecular imaging 2002;29(9):1118-24.
2002: Holger Palmedo
What can we expect from MDR breast cancer imaging with sestamibi?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(4):526-30.
2002: Michael Reinhardt; Alexius Y Joe; Dirk von Mallek; Martina Zimmerlin; Agnieszka Manka-Waluch; Holger Palmedo; Thomas M Krause
Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
European journal of nuclear medicine and molecular imaging 2002;29(4):480-5.
2001: Holger Palmedo; Jürgen K Rockstroh; M Bangard; Kirsten Schliefer; Jörn H Risse; Christian Menzel; Hans-Jürgen Biersack
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study.
Radiology 2001;221(1):256-60.
2001: Jörn H Risse; C Ponath; Holger Palmedo; Christian Menzel; Frank Grünwald; Hans-Jürgen Biersack
Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours.
European journal of nuclear medicine 2001;28(7):914-8.
2000: M Wichers; Edward J Benz; Holger Palmedo; Hans-Jürgen Biersack; Frank Grünwald; Dietrich Klingmüller
Testicular function after radioiodine therapy for thyroid carcinoma.
European journal of nuclear medicine 2000;27(5):503-7.
2000: Holger Palmedo; Stefan Guhlke; Hans Bender; Johannes Sartor; Georg Schoeneich; Jörn H Risse; Frank Grünwald; Furn F Knapp; Hans-Jürgen Biersack
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
European journal of nuclear medicine 2000;27(2):123-30.
2000: Jörn H Risse; Frank Grünwald; W Kersjes; Holger Strunk; W H Caselmann; Holger Palmedo; Hans Bender; Hans-Jürgen Biersack
Intraarterial HCC therapy with I-131-Lipiodol.
Cancer biotherapy & radiopharmaceuticals 2000;15(1):65-70.
1999: Holger Palmedo; Hans Bender; C Dierke-Dzierzon; U M Carl; Jörn H Risse; Dieter Krebs; Hans-Jürgen Biersack
Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
Clinical nuclear medicine 1999;24(9):643-8.
1999: M Bangard; Hans Bender; Frank Grünwald; M Hümmelgen; P Willkomm; Holger Palmedo; Berndt Lüderitz; Hans-Jürgen Biersack
Myocardial uptake of technetium-99m-furifosmin (Q12) versus technetium-99m-sestamibi (MIBI).
Nuklearmedizin. Nuclear medicine 1999;38(6):189-91.
1998: Frank Grünwald; Christian Menzel; Hans Bender; Holger Palmedo; R Otte; R Fimmers; Jörn H Risse; Hans-Jürgen Biersack
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1903-6.
1998: Frank Grünwald; E Pakos; Hans Bender; Christian Menzel; R Otte; Holger Palmedo; Ulrich Pfeifer; Hans-Jürgen Biersack
Redifferentiation therapy with retinoic acid in follicular thyroid cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1555-8.
1998: Holger Palmedo; Frank Grünwald; U Wagner; S Köhler; Dieter Krebs; Hans-Jürgen Biersack
Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Clinical nuclear medicine 1998;23(8):501-4.
1998: Holger Palmedo; Hans-Jürgen Biersack; Secondo Lastoria; Jean Maublant; E Prats; H E Stegner; P Bourgeois; R Hustinx; A J Hilson; A Bischof-Delaloye
Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
European journal of nuclear medicine 1998;25(4):375-85.
1998: Furn F Knapp; Saed Mirzadeh; Arnold L Beets; M O'Doherty; P J Blower; E S Verdera; J S Gaudiano; Joachim Kropp; J Guhlke; Holger Palmedo; Hans-Jürgen Biersack
Reactor-produced radioisotopes from ORNL for bone pain palliation.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1998;49(4):309-15.
1998: Georg Schoeneich; Stefan C Müller; Holger Palmedo
[Indications for nuclear medicine therapy in advanced prostate carcinoma].
Der Urologe. Ausg. A 1998;37(2):162-6.
1998: Frank Grünwald; Holger Palmedo; Peter Mallmann; Hans-Jürgen Biersack
Results of the European multicenter study of radionuclide mammography with Tc-99m-MIBI.
Zentralblatt für Chirurgie 1998;123 Suppl 5():47-8.
1998: P Willkomm; Holger Palmedo; Frank Grünwald; Jürgen Ruhlmann; Hans-Jürgen Biersack
Functional imaging of Hodgkin's disease with FDG-PET and gallium-67.
Nuklearmedizin. Nuclear medicine 1998;37(7):251-3.
1998: A E Hauswirth; Holger Palmedo; C Dierke-Dzierzon; Hans-Jürgen Biersack; Dieter Krebs
[Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
Zentralblatt für Gynäkologie 1998;120(2):83-6.
1997: Georg Schoeneich; Holger Palmedo; C Dierke-Dzierzon; Stefan C Müller; Hans-Jürgen Biersack
Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
Scandinavian journal of urology and nephrology 1997;31(5):445-8.
1997: Holger Palmedo; Hans Bender; Frank Grünwald; Peter Mallmann; PO Zamora; Dieter Krebs; Hans-Jürgen Biersack
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
European journal of nuclear medicine 1997;24(9):1138-45.
1997: Frank Grünwald; Christian Menzel; Hans Bender; Holger Palmedo; P Willkomm; Jürgen Ruhlmann; T Franckson; Hans-Jürgen Biersack
Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer.
Thyroid : official journal of the American Thyroid Association 1997;7(3):327-35.
1997: Furn F Knapp; Arnold L Beets; Stefan Guhlke; PO Zamora; Hans Bender; Holger Palmedo; Hans-Jürgen Biersack
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
Anticancer research 1997;17(3B):1783-95.
1997: Hans Bender; J Kirst; Holger Palmedo; AG Schomburg; U Wagner; Jürgen Ruhlmann; Hans-Jürgen Biersack
Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Anticancer research 1997;17(3B):1687-92.
1996: Christian Menzel; F Grünwald; AG Schomburg; Holger Palmedo; Hans Bender; G Späth; Hans-Jürgen Biersack
"High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1496-503.
1996: Holger Palmedo; AG Schomburg; F Grünwald; Peter Mallmann; I Boldt; Hans-Jürgen Biersack
Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer.
Nuclear medicine and biology 1996;23(6):681-4.
1996: Holger Palmedo; F Grünwald; Hans Bender; AG Schomburg; Peter Mallmann; Dieter Krebs; Hans-Jürgen Biersack
Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
European journal of nuclear medicine 1996;23(8):940-6.
1996: Holger Palmedo; Hans Bender; AG Schomburg; F Grünwald; G Schöneich; P Zamorra; Karl Reichmann; C Dierke-Dzierzon; Peter Mallmann; Hans-Jürgen Biersack
[Pain therapy with rhenium-186 HEDP in multiple bone metastases].
Nuklearmedizin. Nuclear medicine 1996;35(2):63-7.
1996: Holger Palmedo; AG Schomburg; F Grünwald; Peter Mallmann; Dieter Krebs; Hans-Jürgen Biersack
Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(4):626-30.
1996: F Grünwald; AG Schomburg; Hans Bender; Edzard Klemm; Christian Menzel; T Bultmann; Holger Palmedo; Jürgen Ruhlmann; B Kozak; Hans-Jürgen Biersack
Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.
European journal of nuclear medicine 1996;23(3):312-9.
1995: F Grünwald; Holger Palmedo; H J Biersack
Unilateral iodine-131 uptake in the lactating breast.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1724-5.